331 results on '"Fremeaux-Bacchi, Véronique"'
Search Results
2. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
3. Thrombotic Microangiopathy as an Emerging Complication of Viral Vector–Based Gene Therapy
4. De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury
5. Atypical Hemolytic Uremic Syndrome
6. Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma
7. Complement in human disease: approved and up-and-coming therapeutics
8. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features
9. How I diagnose and treat atypical hemolytic uremic syndrome
10. Exome-First Strategy in Adult Patients With CKD: A Cohort Study
11. List of contributors
12. Innate immune responses in COVID-19
13. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
14. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series
15. Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy
16. The Rational Use of Complement Inhibitors in Kidney Diseases
17. Les bloqueurs du complément : nouvelles pistes thérapeutiques en néphrologie
18. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
19. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
20. Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
21. Ex Vivo Complement Activation on Endothelial Cells: Research and Translational Value
22. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients
23. Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
24. Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis
25. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group
26. Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
27. Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties
28. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner
29. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
30. Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome
31. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome
32. Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
33. C3 glomerulopathy — understanding a rare complement-driven renal disease
34. Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies
35. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series
36. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
37. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy
38. Haemolytic uraemic syndrome
39. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy
40. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
41. Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy
42. Atypical Hemolytic Uremic Syndrome
43. P392: Rapid complement mediated TMA diagnosis and early intervention in a renal intensive care unit using Nanopore technology
44. Defining the genetics of thrombotic microangiopathies
45. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome
46. Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria
47. Disseminated Cryptococcosis Following Eculizumab Therapy: Insight Into Pathogenesis
48. The emerging role of complement inhibitors in transplantation
49. Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis
50. Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.